Life Science Solutions
News
Sorry, this page is not
available in your country.
| EVIDENT Announces Alliance to Automate Digital Pathology Workflows We have announced an alliance with Corista, Sakura Finetek USA, and Visiopharm to deliver an automated, end-to-end workflow solution for pathology. Get all the details in the press release. |
| 胃がんAI病理診断支援ソフトウェア、連続症例における評価でAUC0.96を達成 独立行政法人国立病院機構呉医療センター・中国がんセンター（院長：下瀨 省二）を含む国内医療機関7施設との共同研究で開発した胃がんAI病理診断支援ソフトウェアが、学習データに使用していない施設での連続症例における評価でAUC0.96を達成しました。 |
| EVIDENT Corporation Appoints New CEO and COO Evident Corporation (“Evident”) announced the appointment of William Wesley “Wes” Pringle as Chief Executive Officer (CEO) and Hiroyuki Yoshimoto as President and Chief Operating Officer (COO). Effective immediately, Wes takes over for Evident’s interim CEO Eric Anderson. |
| EVIDENT Announces 2022 Global Image of the Year Award Winners The results are in! Discover the winners of our 2022 Global Image of the Year Scientific Light Microscopy Award, an annual competition that recognizes the best in scientific imaging worldwide. Learn more in the press release. |
| EVIDENT Discovery Center Inaugurated at the University of Montreal |
| The SLIDEVIEW™ DX Combines Microscope-Quality Images with Fast Slide Scanning for Efficient Digital Pathology |
| ホールスライドイメージングシステム「SLIDEVIEW VS-M1J」を発売 株式会社エビデント（本社：東京都新宿区、社長：エリック アンダーソン）は、病理検査向けにスライドガラス標本を画像データ化するホールスライドイメージングシステム「SLIDEVIEW VS-M1J（スライドビュー ヴイエス-エムワンジェイ）」を2023年6月1日より国内で発売します。 |
| Evident Announces Interim CEO Evident Corporation (“Evident”) today announced the appointment of Eric Anderson, a current member of the Office of the CEO, as Interim CEO. He takes on the responsibilities of Yoshitake Saito, who assumes the role of Chairman effective immediately. |
| SLIDEVIEW™ VS200 Adds Optical Sectioning Device for High-Contrast, Blur-Free Imaging |
| Evident Acquired by Bain Capital: Partnership to Accelerate Future Growth and Innovation |
| Notice Concerning Postponement of Closing of Transfer of Shares of Evident Corporation |
| Postponement of the Transfer of all Shares of EVIDENT Corporation from Olympus to Bain Capital |
| 2023 EVIDENT Organoid Conference to Share the Latest Organoid Innovations |
Not Available in Your Country
Sorry, this page is not
available in your country.
You are being redirected to our local site.